losatrix comp 50 mg / 12.5 mg tabletti, kalvopäällysteinen
teva sweden ab - hydrochlorothiazide, losartan potassium - tabletti, kalvopäällysteinen - 50 mg / 12.5 mg - losartaani ja diureetit
losatrix comp 100 mg / 25 mg tabletti, kalvopäällysteinen
teva sweden ab - hydrochlorothiazide, losartan potassium - tabletti, kalvopäällysteinen - 100 mg / 25 mg - losartaani ja diureetit
losarstad comp 50 mg / 12.5 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - hydrochlorothiazide, losartan potassium - tabletti, kalvopäällysteinen - 50 mg / 12.5 mg - losartaani ja diureetit
losarstad comp 100 mg / 25 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - hydrochlorothiazide, losartan potassium - tabletti, kalvopäällysteinen - 100 mg / 25 mg - losartaani ja diureetit
losarstad comp 100 mg / 12.5 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - hydrochlorothiazide, losartan potassium - tabletti, kalvopäällysteinen - 100 mg / 12.5 mg - losartaani ja diureetit
azyter 15 mg/g silmätipat, liuos, kerta-annospakkaus
laboratoires thea - azithromycin dihydrate - silmätipat, liuos, kerta-annospakkaus - 15 mg/g - atsitromysiini
arikayce liposomal
insmed netherlands b.v. - amikacin sulfate - hengitystietulehdukset - systeemiset bakteerilääkkeet, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubisiinihydrokloridia - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiset aineet - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
genotropin 12 mg injektiokuiva-aine ja liuotin, liuosta varten
pfizer oy - somatropin - injektiokuiva-aine ja liuotin, liuosta varten - 12 mg - somatropiini